Claire Schwab Dr Ruth Cranston Dr Sarra Ryan Ellie Butler Emily Winterman et al. | Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial | 2023 |
|
Sarra Ryan Dr Ruth Cranston Claire Schwab Dr Matthew Bashton Dr Paul Sinclair et al. | The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 | 2023 |
|
Dr Stacey Richardson Dr Rebecca Hill Dr Christopher Kui Dr Janet Lindsey Dr Yura Grabovska et al. | Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse | 2022 |
|
Dr Christopher Duncan Dr Rebecca Payne Dr Darren Smith Dr Matthew Bashton Dr Roy Sanderson et al. | Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway (Nature Microbiology, (2022), 7, 8, (1161-1179), 10.1038/s41564-022-01143-7) | 2022 |
|
Dr Yusri Taha Dr Ewan Hunter Dr Wendy Osborne Dr Matthew Bashton Dr Darren Smith et al. | Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy | 2021 |
|
Dr Matthew Bashton Professor Christine Harrison FRCPath FMedSci
| IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia | 2019 |
|
Dr Paul Sinclair Dr Sarra Ryan Dr Matthew Bashton Shaun Hollern Rebecca Hanna et al. | SH2B3 inactivation through CN-LOH-12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain | 2019 |
|
Dr Ruth Cranston Dr Paul Sinclair Dr Matthew Bashton Dr Matthew Selby Professor Christine Harrison FRCPath FMedSci et al. | A Genome-Wide CRISPR Screen Implicates MYC Dysregulation in TCF3-PBX1 B-ALL | 2018 |
|
Dr Paul Sinclair Dr Helen Blair Dr Sarra Ryan Dr Lars Buechler Joanna Cheng et al. | Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 | 2018 |
|
Dr Lauren Walker Dr Jonathan Coxhead Dr Ian Wilson Dr Matthew Bashton Dr Christopher Morris et al. | High prevalence of focal and multi-focal somatic genetic variants in the human brain | 2018 |
|
Dr Ed Schwalbe Dr Debbie Hicks Dr Reza Rafiee Dr Matthew Bashton Dr Amir Enshaei et al. | Minimal methylation classifier (MIMIC): A novel method for derivation and rapid diagnostic detection of disease-associated DNA methylation signatures | 2017 |
|
Dr Mujdat Zeybel Dr Timothy Hardy Gemma Zeybel Dr Matthew Bashton Professor John Mathers et al. | DNA methylation profiling identifies novel markers of progression in hepatitis B-related chronic liver disease | 2016 |
|
Dr Martina Finetti Matthew Selby Dr Matthew Bashton Dr Ruth Cranston Dr Stephen Crosier et al. | Integrated pathway analysis of malignant rhabdoid tumour identifies key SMARCB1-pathways and therapeutic opportunities | 2016 |
|
Matthew Selby Dr Martina Finetti Dr Matthew Bashton Dr Ruth Cranston Alicia Del Carpio Pons et al. | Investigating the biology of atypical teratoid/rhabdoid tumors by whole genome CRISPR/CAS9 screening | 2016 |
|
Dr Ed Schwalbe Dr Debbie Hicks Dr Reza Rafiee Dr Matthew Bashton Dr Amir Enshaei et al. | Routine Diagnostic Medulloblastoma Subgrouping Using Low-Cost, Low-Input DNA Methylomics: Application to Trials Cohorts Previously Refractory-to-Analysis | 2016 |
|
Dr Ed Schwalbe Dr Debbie Hicks Dr Reza Rafiee Dr Matthew Bashton Dr Amir Enshaei et al. | Routine molecular subgrouping of medulloblastoma: Bridging the divide between research and the clinic using low-cost, mass spectrometry-based DNA methylomics | 2016 |
|
Dr Sarra Ryan Elizabeth Matheson Dr Paul Sinclair Dr Matthew Bashton Claire Schwab et al. | The role of the RAS pathway in iAMP21-ALL | 2016 |
|
Dr Daniel Williamson Dr Janet Lindsey Dr Debbie Hicks Dr Stephen Crosier Amanda Smith et al. | The Transcriptional Landscape of Medulloblastoma: Group 3 and Group 4 Tumours Comprise a Single Clinically Significant Expression Continuum | 2016 |
|
Katie Dormon Elda Latif Dr Matthew Bashton Dr Deepali Pal Dr Helen Blair et al. | A Whole Genome In Vivo Crispr Screen in Primary ALL Predicts Leukaemic Relapse | 2015 |
|
Professor Nicholas Jakubovics Jill Robinson Dr Matthew Bashton
| Critical Roles of Arginine in Growth and Biofilm Development by Streptococcus gordonii | 2015 |
|
Dr Simon Cockell Dr Matthew Bashton Dr Colin Gillespie
| Bioconductor tools for microarray data analysis | 2014 |
|
Dr Matthew Bashton
| Crowdsourced analysis of ash and ash dieback through the Open Ash Dieback project: A year 1 report on datasets and analyses contributed by a self-organising community | 2014 |
|
Dr Matthew Bashton
| Crowdsourcing genomic analyses of ash and ash dieback – power to the people | 2013 |
|
Dr Matthew Bashton
| Domain-ligand mapping for enzymes | 2010 |
|
Dr Matthew Bashton
| Small Molecule Subgraph Detector (SMSD) toolkit | 2009 |
|
Dr Matthew Bashton
| PROCOGNATE: a cognate ligand domain mapping for enzymes | 2008 |
|
Dr Matthew Bashton
| The generation of new protein functions by the combination of domains | 2007 |
|
Dr Matthew Bashton
| Cognate ligand domain mapping for enzymes | 2006 |
|
Dr Matthew Bashton
| Structure, function and evolution of multidomain proteins | 2004 |
|
Dr Matthew Bashton
| Supra-domains: evolutionary units larger than single protein domains | 2004 |
|
Dr Matthew Bashton
| The geometry of domain combination in proteins | 2002 |
|